Important points
- 21Shares has filed a new ETF focused on Injective, a blockchain protocol designed for global financial infrastructure.
- The filing highlights institutions’ growing interest in integrating digital assets into traditional financial portfolios.
21Shares, a leading issuer of exchange-traded products focused on cryptocurrencies, today filed a new ETF targeting Injective, a blockchain protocol positioned as an infrastructure for global finance, with features such as high-performance consensus and native financial primitives.
The filing represents a new expansion of institutional crypto investment products as traditional finance continues to integrate digital assets. 21Shares recently expanded its listing on major exchanges to retail investors in the UK.
The company has been actively introducing new exchange-traded products for a variety of digital assets, including those focused on decentralized computing and artificial intelligence. 21Shares has worked with foundations and exchanges to launch approved products, including meme coins and products related to the scalable Web3 architecture.
The move signals broader integration of digital assets into mainstream portfolios, as entities like 21Shares work to simplify access to the blockchain ecosystem through regulated investment vehicles.
